The appointment is part of Pfizer's broader strategy to enhance its anti?obesity portfolio and secure a stronger global market presence.
Why Trust Us? For one month, I put the entire Clear System line to the test, keeping an eye on the ways each product felt on my skin, how effectively they axed acne, and how clear they left my ...
Pfizer's CEO said he may move manufacturing back to the US in response to Donald Trump's tariffs. Albert Bourla said he was not surprised by Trump's victory in November. Trump has threatened to ...
Pfizer PFE-0.53%decrease; red down pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...
Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big Pharma after GSK (NYSE:GSK) to revise DEI initiatives amid the Trump ...
Pfizer already has 13 U.S. manufacturing sites up and running, including several “megasites” for sterile injectables and antibody manufacturing, according to Bourla.
March 3 (Reuters) - Pfizer (PFE.N), opens new tab CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United States, if required ...
With summers approaching, incidence of acne and skin breakouts is on a hike. The real cause behind this is not the sweat, rather its interaction with skin, bacteria and skin sebum. To prevent heat ...
Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous tariffs on imported goods, Reuters’ Christy Santhosh ...
Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing ...
Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...